Pierre Chaillet

1.2k total citations
20 papers, 969 citations indexed

About

Pierre Chaillet is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Pierre Chaillet has authored 20 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Pierre Chaillet's work include Neuropeptides and Animal Physiology (15 papers), Peptidase Inhibition and Analysis (8 papers) and Receptor Mechanisms and Signaling (6 papers). Pierre Chaillet is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Peptidase Inhibition and Analysis (8 papers) and Receptor Mechanisms and Signaling (6 papers). Pierre Chaillet collaborates with scholars based in France. Pierre Chaillet's co-authors include Jean Costentin, H Marçais-Collado, Sophie De La Baume, Bernárd P. Roques, Jean‐Charles Schwartz, Marie‐Claude Fournié‐Zaluski, Gilles Waksman, Romaine Bouboutou, J.C. Schwartz and J.C. Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Pierre Chaillet

20 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Chaillet France 14 789 597 328 302 65 20 969
József I. Székely Hungary 21 826 1.0× 785 1.3× 328 1.0× 60 0.2× 33 0.5× 59 1.2k
Heidi A. Woody United States 5 611 0.8× 550 0.9× 229 0.7× 40 0.1× 49 0.8× 7 841
James H. Crona United States 13 432 0.5× 912 1.5× 155 0.5× 158 0.5× 50 0.8× 15 1.2k
H. YAJIMA Japan 14 329 0.4× 311 0.5× 92 0.3× 55 0.2× 50 0.8× 36 619
Atsushi Nagahisa United States 19 519 0.7× 517 0.9× 289 0.9× 60 0.2× 39 0.6× 29 1.1k
H. Paris France 17 241 0.3× 535 0.9× 143 0.4× 76 0.3× 118 1.8× 39 827
Jean Camus Belgium 22 468 0.6× 590 1.0× 75 0.2× 95 0.3× 95 1.5× 35 840
Kazuhiko Kubota Japan 14 245 0.3× 356 0.6× 128 0.4× 61 0.2× 13 0.2× 72 644
Viachaslau Bernat Germany 7 496 0.6× 780 1.3× 119 0.4× 61 0.2× 22 0.3× 8 970
Hans-Jürgen Hess United States 7 588 0.7× 522 0.9× 224 0.7× 36 0.1× 34 0.5× 10 808

Countries citing papers authored by Pierre Chaillet

Since Specialization
Citations

This map shows the geographic impact of Pierre Chaillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chaillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chaillet more than expected).

Fields of papers citing papers by Pierre Chaillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chaillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chaillet. The network helps show where Pierre Chaillet may publish in the future.

Co-authorship network of co-authors of Pierre Chaillet

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Chaillet. A scholar is included among the top collaborators of Pierre Chaillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Chaillet. Pierre Chaillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaumont, Ann, Jean‐François Hernandez, Pierre Chaillet, Philippe Crine, & B P Roques. (1987). Irreversible photolabeling of active site of neutral endopeptidase-24.11 "enkephalinase" by azidothiorphan and [14C]-azidothiorphan.. Molecular Pharmacology. 32(5). 594–599. 5 indexed citations
2.
Lecomte, J, Jean Costentin, Pierre Chaillet, et al.. (1986). Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 237(3). 937–944. 122 indexed citations
3.
Costentin, Jean, et al.. (1986). Dissociated effects of inhibitors of enkephalin-metabolising peptidase or naloxone on various nociceptive responses. European Journal of Pharmacology. 123(1). 37–44. 55 indexed citations
4.
5.
Fournié-Zaluski, Marie Claude, Romaine Bouboutou, Pierre Chaillet, et al.. (1985). New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties. Journal of Medicinal Chemistry. 28(9). 1158–1169. 60 indexed citations
6.
Fournié‐Zaluski, Marie‐Claude, Pierre Chaillet, Romaine Bouboutou, et al.. (1984). Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. European Journal of Pharmacology. 102(3-4). 525–528. 142 indexed citations
7.
Chaillet, Pierre, et al.. (1984). The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia. European Journal of Pharmacology. 101(1-2). 83–90. 84 indexed citations
8.
Chaillet, Pierre, et al.. (1984). Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.. PubMed. 15(3). 375–83. 1 indexed citations
9.
Chaillet, Pierre, et al.. (1984). Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ test. European Journal of Pharmacology. 97(3-4). 301–304. 23 indexed citations
10.
Chaillet, Pierre, et al.. (1983). Pain control by endogenous enkephalins is mediated by MU opioid receptors. Life Sciences. 33. 685–688. 13 indexed citations
11.
Roques, B. P., et al.. (1983). Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.. Proceedings of the National Academy of Sciences. 80(11). 3178–3182. 69 indexed citations
12.
Baume, Sophie De La, et al.. (1983). Participation of both ‘enkephalinase’ and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience. 8(1). 143–151. 128 indexed citations
13.
Chaillet, Pierre, H Marçais-Collado, & Jean Costentin. (1983). Catatonic or hypotonic immobility induced in mice by intracerebroventricular injection of mu or kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation. Life Sciences. 33(21). 2105–2111. 22 indexed citations
14.
Fournié-Zaluski, Marie Claude, et al.. (1983). New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity and analgesic properties. Journal of Medicinal Chemistry. 26(1). 60–65. 25 indexed citations
15.
Jc, Schwartz, et al.. (1983). Peptidases involved in the inactivation of exogenous and endogenous enkephalins.. PubMed. 18. 235–43. 7 indexed citations
16.
Marçais-Collado, H, Pierre Chaillet, & Jean Costentin. (1983). Inhibition of the spontaneous climbing behavior elicited in mice by opiates.. Journal of Pharmacology and Experimental Therapeutics. 227(2). 466–471. 10 indexed citations
17.
Chaillet, Pierre, et al.. (1983). Inhibition of enkepha,in metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. European Journal of Pharmacology. 86(3-4). 329–336. 123 indexed citations
18.
Baume, Sophie De La, Claude P. Gros, Chenju Yi, et al.. (1982). Selective participation of both “enkephalinase” and aminopeptidase activities in the metabolism of endogenous enkephalins. Life Sciences. 31(16-17). 1753–1756. 32 indexed citations
19.
Schwartz, Jean‐Charles, et al.. (1982). Enkephalin metabolism in brain and its inhibition. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 6(4-6). 665–671. 17 indexed citations
20.
Roques, B.P., M.-C. Fournié-Zaluski, Dominique Florentin, et al.. (1982). New enkephalinase inhibitors as probes to differentiate “enkephalinase” and angiotensin-converting-enzyme active sites. Life Sciences. 31(16-17). 1749–1752. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by József I. Székely Breakdown of academic impact, for papers by Heidi A. Woody Breakdown of academic impact, for papers by James H. Crona Breakdown of academic impact, for papers by H. YAJIMA Breakdown of academic impact, for papers by Atsushi Nagahisa Breakdown of academic impact, for papers by H. Paris Breakdown of academic impact, for papers by Jean Camus Breakdown of academic impact, for papers by Kazuhiko Kubota Breakdown of academic impact, for papers by Viachaslau Bernat Breakdown of academic impact, for papers by Hans-Jürgen Hess
Rankless by CCL
2026